Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 7.450% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CC(O)[C@H]1CNC(=O)C(=O)N1CCC12CC3CC(CC(C3)C1)C2
(b) Cc1ccccc1C1CCCN(Cc2nc(CC3CC3)no2)C1
Answer: a. CC(O)[C@H]1CNC(=O)C(=O)N1CCC12CC3CC(CC(C3)C1)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(O)[C@H]1CNC(=O)C(=O)N1CCC12CC3CC(CC(C3)C1)C2
CC(O)[C@H]1CNC(=O)C(=O)N1CCC12CC3CC(CC(C3)C1)C2
(6R)-1-[2-(1-adamantyl)ethyl]-6-(1-hydroxyethyl)piperazine-2,3-dione